EIM
ARGS

Essex Investment Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

Essex Investment Management’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,227
Closed -$445K – 405
2014
Q1 		$445K Buy
+2,227
New +$445K 0.06% 256

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Essex Investment Management's ARGS Position: Q2 2014 in Review

Essex Investment Management sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2014, closing a stake of 2,227 shares — an estimated $445K sold.

Essex Investment Management first reported a position in ARGS in Q1 2014 and held it in 1 quarter. The position peaked at $445K in Q1 2014. 30 funds tracked by Wall St. Rank hold ARGS as of Q2 2014.

  • Essex Investment Management reported no remaining Argos Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
  • Essex Investment Management sold 2,227 Argos Therapeutics, Inc. shares in Q2 2014, an estimated $445K.
  • Essex Investment Management first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 1 quarter.
  • Essex Investment Management's Argos Therapeutics, Inc. position peaked at $445K in Q1 2014.
  • 30 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2014.

Based on Essex Investment Management's 13F filing for Q2 2014, filed 23 Jul 2014.